| Dr Steven M Korotkin, MD | |
|
32270 Telegraph Rd, Ste 100, Bingham Farms, MI 48025-2456 | |
| (248) 258-2888 | |
| (248) 258-6849 |
| Full Name | Dr Steven M Korotkin |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 51 Years |
| Location | 32270 Telegraph Rd, Bingham Farms, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396736179 | NPI | - | NPPES |
| 2096430 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 4301035974 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Beaumont Hospital - Farmington Hills | Farmington hills, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cardiology Associates Of Birmingham Pc | 5496749202 | 2 |
News Archive
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative treatments for diabetic eye disease, today announces that the first patient has been enrolled in its Phase II CIRCLE study evaluating the efficacy and safety of multiple doses of ocriplasmin in inducing total posterior vitreous detachment (PVD) in patients with non-proliferative diabetic retinopathy (NPDR).
WHO Director-General Margaret Chan on Monday laid out her vision for reforming the international health agency in the opening address of the World Health Assembly in Geneva, saying she sees "a WHO that gives a bigger voice to the many partners working on health, but encourages them to speak with a coherent voice that responds, first and foremost, to the needs and priorities as defined by recipient countries," Intellectual Property Watch reports.
Researchers have identified an apparent cause of inguinal hernia, or groin hernia, in older men: altered sex hormone levels that weaken and scar muscle tissue in the lower abdomen.
› Verified 6 days ago
| Entity Name | Cardiology Associates Of Birmingham Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912079138 PECOS PAC ID: 5496749202 Enrollment ID: O20040414000144 |
News Archive
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative treatments for diabetic eye disease, today announces that the first patient has been enrolled in its Phase II CIRCLE study evaluating the efficacy and safety of multiple doses of ocriplasmin in inducing total posterior vitreous detachment (PVD) in patients with non-proliferative diabetic retinopathy (NPDR).
WHO Director-General Margaret Chan on Monday laid out her vision for reforming the international health agency in the opening address of the World Health Assembly in Geneva, saying she sees "a WHO that gives a bigger voice to the many partners working on health, but encourages them to speak with a coherent voice that responds, first and foremost, to the needs and priorities as defined by recipient countries," Intellectual Property Watch reports.
Researchers have identified an apparent cause of inguinal hernia, or groin hernia, in older men: altered sex hormone levels that weaken and scar muscle tissue in the lower abdomen.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven M Korotkin, MD 32270 Telegraph Rd, Ste 100, Bingham Farms, MI 48025-2456 Ph: (248) 258-2888 | Dr Steven M Korotkin, MD 32270 Telegraph Rd, Ste 100, Bingham Farms, MI 48025-2456 Ph: (248) 258-2888 |
News Archive
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.
ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative treatments for diabetic eye disease, today announces that the first patient has been enrolled in its Phase II CIRCLE study evaluating the efficacy and safety of multiple doses of ocriplasmin in inducing total posterior vitreous detachment (PVD) in patients with non-proliferative diabetic retinopathy (NPDR).
WHO Director-General Margaret Chan on Monday laid out her vision for reforming the international health agency in the opening address of the World Health Assembly in Geneva, saying she sees "a WHO that gives a bigger voice to the many partners working on health, but encourages them to speak with a coherent voice that responds, first and foremost, to the needs and priorities as defined by recipient countries," Intellectual Property Watch reports.
Researchers have identified an apparent cause of inguinal hernia, or groin hernia, in older men: altered sex hormone levels that weaken and scar muscle tissue in the lower abdomen.
› Verified 6 days ago
Dr. Patricia Ann Schmidt, D.O. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 30400 Telegraph Rd, Suite 334, Bingham Farms, MI 48025 Phone: 800-311-5365 Fax: 248-681-8927 | |
Justin Elijah Trivax, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 31500 Telegraph Rd, Suite 115, Bingham Farms, MI 48025 Phone: 248-594-4913 Fax: 248-594-4928 | |
Rushdah Saeed Malik, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 31500 Telegraph Rd, Ste 225, Bingham Farms, MI 48025 Phone: 248-552-0620 Fax: 248-530-9899 | |
Ms. Elizabeth J Stellema, NP-C Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 30800 Telegraph Rd, Bingham Farms, MI 48025 Phone: 248-347-9437 | |
Dr. Judith L Bateman, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 32270 Telegraph Rd, Suite 120, Bingham Farms, MI 48025 Phone: 248-646-1965 Fax: 248-646-7293 | |
David Wolf, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 31500 Telegraph Rd, Ste 230, Bingham Farms, MI 48025 Phone: 248-593-9933 Fax: 248-593-5658 |